For example, CD19 CAR-T cells with RASA2 knockout demonstrated enhanced adaptability and effector functions in a B-cell acute lymphoblastic leukemia (B-ALL) mouse model [12]. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.